Literature DB >> 28233428

A Dual Functional Scaffold Tethered with EGFR Antibody Promotes Neural Stem Cell Retention and Neuronal Differentiation for Spinal Cord Injury Repair.

Bai Xu1, Yannan Zhao2, Zhifeng Xiao2, Bin Wang2, Hui Liang1, Xing Li1,2, Yongxiang Fang2, Sufang Han2, Xiaoran Li1, Caixia Fan1, Jianwu Dai1,2.   

Abstract

Neural stem cells (NSCs) transplantation is a promising strategy to restore neuronal relays and neurological function of injured spinal cord because of the differentiation potential into functional neurons, but the transplanted NSCs often largely diffuse from the transplanted site and mainly differentiate into glial cells rather than neurons due to the adverse microenviornment after spinal cord injury (SCI). This paper fabricates a dual functional collagen scaffold tethered with a collagen-binding epidermal growth factor receptor (EGFR) antibody to simultaneously promote NSCs retention and neuronal differentiation by specifically binding to EGFR molecule expressed on NSCs and attenuating EGFR signaling, which is responsible for the inhibition of differentiation of NSCs toward neurons. Compared to unmodified control scaffold, the dual functional scaffold promotes the adhesion and neuronal differentiation of NSCs in vitro. Moreover, the implantation of the dual functional scaffold with exogenous NSCs in rat SCI model can capture and retain NSCs at the injury sites, and promote the neuronal differentiation of the retained NSCs into functional neurons, and finally dedicate to improving motor function of SCI rats, which provides a potential strategy for synchronously promoting stem cell retention and differentiation with biomaterials for SCI repair.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  collagen binding single-chain EGFR antibody; functional collagen scaffold; myelin; neural stem cells; spinal cord injury

Mesh:

Substances:

Year:  2017        PMID: 28233428     DOI: 10.1002/adhm.201601279

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  7 in total

Review 1.  The neuronal differentiation microenvironment is essential for spinal cord injury repair.

Authors:  Yannan Zhao; Zhifeng Xiao; Bing Chen; Jianwu Dai
Journal:  Organogenesis       Date:  2017-06-09       Impact factor: 2.500

Review 2.  Cell Therapeutic Strategies for Spinal Cord Injury.

Authors:  Pinghui Zhou; Jingjing Guan; Panpan Xu; Jingwen Zhao; Changchun Zhang; Bin Zhang; Yingji Mao; Wenguo Cui
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

Review 3.  Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis.

Authors:  Jasper Van den Bos; Yousra El Ouaamari; Kristien Wouters; Nathalie Cools; Inez Wens
Journal:  Biomolecules       Date:  2022-02-21

Review 4.  Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms.

Authors:  Atefeh Zarepour; Sara Hooshmand; Aylin Gökmen; Ali Zarrabi; Ebrahim Mostafavi
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

5.  White matter regeneration induced by aligned fibrin nanofiber hydrogel contributes to motor functional recovery in canine T12 spinal cord injury.

Authors:  Zheng Cao; Weitao Man; Yuhui Xiong; Yi Guo; Shuhui Yang; Dongkang Liu; He Zhao; Yongdong Yang; Shenglian Yao; Chuzhong Li; Lingyun Zhao; Xiaodan Sun; Hua Guo; Guihuai Wang; Xiumei Wang
Journal:  Regen Biomater       Date:  2021-11-29

Review 6.  Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.

Authors:  Tianyi Liu; Wenhao Zhu; Xiaoyu Zhang; Chuan He; Xiaolong Liu; Qiang Xin; Kexin Chen; Haifeng Wang
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

7.  Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury.

Authors:  Wei Liu; Peng Quan; Qingqing Li; Pengyu Tang; Jian Chen; Tao Jiang; Weihua Cai
Journal:  Int J Nanomedicine       Date:  2018-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.